Overview
The purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design of future clinical trials of this technique.
Eligibility
Inclusion Criteria:
- Study subjects will be patients who meet the International Classification of Headache
- Disorders 3rd Edition (ICHD-3) criteria for a diagnosis of SIH or the Schievink criteria with imaging confirmed CSF-venous fistulas on DSM or CTM.
- Availability of a clinically prescribed contrast enhanced MRI positive for SIH.
- Negative urine or serum pregnancy test at time of study consent and three-months.
Exclusion Criteria:
- Patients who have a contraindication or inability to undergo the procedure (i.e., severe contrast allergy).
- Inability to provide informed consent.
- Expected inability to complete the follow-up assessment.
- Current pregnancy or breast-feeding during study enrollment (from consent to study conclusion approximately 90-days).